Market Place
Sourcing Support
Lupin launches Bumetanide Injection USP in US
20 Nov 2024 //
INDPHARMAPOST
BeiGene defends Brukinsa from MSN`s generic threat until 2037
19 Nov 2024 //
FIERCE PHARMA
Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
18 Nov 2024 //
REUTERS
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
12 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules
11 Nov 2024 //
BUSINESS STD
Lupin receives tentative FDA approval for Raltegravir tablets
11 Nov 2024 //
EXPRESSPHARMA
Hefty sales of generics boost Teva to another big quarter
07 Nov 2024 //
FIERCE PHARMA
Teva Reports Strong Q3 2024 Results, Raises Financial Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Walgreens agrees to pay $100 mlnt over generic drug pricing
04 Nov 2024 //
REUTERS
AVET Pharma Settles Antitrust Case in Generic Pharma Pricing
04 Nov 2024 //
PR NEWSWIRE
PL Developments Gets FDA Approval for Omeprazole OTC
28 Oct 2024 //
PR NEWSWIRE
EpiVax And CUBRC Awarded $2M FDA Contract For Control Peptides
24 Oct 2024 //
PR NEWSWIRE
FDA Launches Pilot For Transparency On Generic Drug Delays
21 Oct 2024 //
ENDPTS
Alembic Pharma gets FDA nod for generic hypertension capsules
21 Oct 2024 //
ECONOMICTIMES
Judge upholds MSN`s generic Entresto nod amid Novartis challenge
19 Oct 2024 //
FIERCE PHARMA
Zydus gains FDA approval for Fludrocortisone Acetate Tablets
18 Oct 2024 //
EXPRESSPHARMA
Novartis loses latest bid to block generic version of blockbuster heart drug
17 Oct 2024 //
REUTERS
Lupin launches first generic of Pred Forte in the US
16 Oct 2024 //
EXPRESSPHARMA
Commit Biologics appoints Mikkel Wandahl Pedersen as CSO
15 Oct 2024 //
PR NEWSWIRE
Teva to pay $450M to settle longstanding kickback allegations
14 Oct 2024 //
FIERCE PHARMA
Sandoz US launches generic paclitaxel in single-dose vial
11 Oct 2024 //
GLOBENEWSWIRE
Zydus gets US nod for schizophrenia generic medicine
11 Oct 2024 //
ECONOMICTIMES
FDA Confirms Para IV Patent Litigation for Cresemba Injection
09 Oct 2024 //
FDA
FDA Confirms Para IV Patent Litigation for (Winlevi) Clascoterone
09 Oct 2024 //
FDA
Curia Commits to SBTi Net-Zero Standard
08 Oct 2024 //
GLOBENEWSWIRE
Novo settles with Mylan over potential Ozempic generic
07 Oct 2024 //
FIERCE PHARMA
Natco shares rise 4% order in US patent case over generic Ozempic
07 Oct 2024 //
MONEYCONTROL
Indoco receives U.S. FDA approval for generic Cetirizine tablets
05 Oct 2024 //
EXPRESSPHARMA
Emcure Pharma partners with Gilead Sciences to produce HIV drug
04 Oct 2024 //
PRESS RELEASE
Alembic gains FDA approval for Lamotrigine Extended-Release Tablets
04 Oct 2024 //
EXPRESSPHARMA
Access To HIV Drug Hinges On Waiver Of Local Clinical Trials
03 Oct 2024 //
ECONOMICTIMES
Alembic Gains USFDA Approval For Lamotrigine Extended-Release
03 Oct 2024 //
EXPRESSPHARMA
Dr Reddy`s sign voluntary licenses with Gilead for HIV drug
02 Oct 2024 //
PRESS RELEASE
Gilead inks licensing deals to boost lenacapivir access
02 Oct 2024 //
FIERCE PHARMA
Teva Launches First Generic Version of Sandostatin® LAR Depot
01 Oct 2024 //
GLOBENEWSWIRE
Alembic Pharma gets USFDA nod for schizophrenia Drug
28 Sep 2024 //
ECOMONICTIMES
Amneal asks court to block Colorado`s free allergy pen program
23 Sep 2024 //
REUTERS
Lupin gets US FDA nod for Bumetanide Injection, USP
19 Sep 2024 //
EXPRESSPHARMA
Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
18 Sep 2024 //
EXPRESSPHARMA
CivicaScript™ Names Brent J. Eberle its New President
17 Sep 2024 //
PR NEWSWIRE
Strides gets USFDA nod for Theophylline extended-release tablets
07 Sep 2024 //
ECONOMICTIMES
Minafin appoints Olivier Ubrich as CEO of Health Chemistry Division
05 Sep 2024 //
PRESS RELEASE
DEA Increases Production Limits on Takeda`s Vyvanse Amid Ongoing Shortages
05 Sep 2024 //
FIERCE PHARMA
Walgreens Sued Over Cancer-Causing Chemical In Generic Cold Medicine
05 Sep 2024 //
REUTERS
Apotex Launches First Generic Dasatinib Tablets in the United States
04 Sep 2024 //
PR NEWSWIRE
Zydus gains final USFDA tentative approval for Amantadine ER capsule
03 Sep 2024 //
EXPRESSPHARMA
Biocon unit gets USFDA nod for generic drug
02 Sep 2024 //
ECONOMICTIMES
Zydus Lifesciences gets USFDA nod for generic medication
29 Aug 2024 //
CONTRACT PHARMA
Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution
28 Aug 2024 //
EXPRESSPHARMA
Fresenius Kabi Expands Women`s Health Portfolio With Generic Option
27 Aug 2024 //
BUSINESSWIRE
Alembic Pharma gets USFDA nod for generic drug
26 Aug 2024 //
ECONOMICTIMES
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024
26 Aug 2024 //
ACCESSWIRE
Vistin Pharma ASA: Mandatory notification of trade
23 Aug 2024 //
GLOBENEWSWIRE
Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
21 Aug 2024 //
FIERCE PHARMA
Ipca Labs expects its US generics sales to touch $200 million soon
21 Aug 2024 //
ECONOMICTIMES
Granules India gets USFDA nod for generic Glycopyrrolate oral solution
20 Aug 2024 //
PRESS RELEASE
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
Novartis loses initial bid to block generic of best-selling heart drug
13 Aug 2024 //
REUTERS
Alembic gets USFDA nod for generic medication
13 Aug 2024 //
ECONOMICTIMES
